Opening Up Innovation

Opening Up Innovation

By • on November 15, 2016

The pmlive website noted that the [pharma] industry is increasingly open to academic collaborations and alongside this a more radical step can be seen in pharma’s willingness to move beyond ‘not invented here’ and take part in ‘open innovation’ initiatives. The trend is an acknowledgement that it is impossible to maintain

Comments Off on Opening Up InnovationRead this story »

More Articles

Radical Experiment Changing the Way Big Pharma Innovates

Radical Experiment Changing the Way Big Pharma Innovates

By • on July 24, 2016

The Fortune website noted that in the highly competitive, IP-obsessed world of drug development, throwing open the doors and inviting people in, is a departure in strategy to say the least. Yet, such is the surprising concept behind JLABS, the “no strings attached” incubator that Johnson & Johnson

Comments Off on Radical Experiment Changing the Way Big Pharma InnovatesRead this story »

Open Innovation and Big Pharma

Open Innovation and Big Pharma

By • on May 4, 2016

The PMLive website reported that there has been a major drive towards an open innovation model among big pharma companies, seeking to forge closer ties with small biopharma companies and academic groups in recognition that relying on in-house pharma R&D is no longer enough to remain competitive.

Comments Off on Open Innovation and Big PharmaRead this story »

Changing the Model for Pharma Innovation

Changing the Model for Pharma Innovation

By • on December 22, 2015

The PharmTech website noted that at this point, for many companies, results suggest that the desire and commitment to open innovation may be there, but questions of risk and reward remain. For now, for many companies, open innovation is a work in progress, but the factors driving this trend are not

Comments Off on Changing the Model for Pharma InnovationRead this story »

Eli Lilly: Partnerships Better than Acquisitions

Eli Lilly: Partnerships Better than Acquisitions

By • on December 14, 2015

The Nikkei Asian Review website reported that Eli Lilly has drawn a line from expensive mergers and acquisitions, and intends to focus on partnerships for innovation; on open innovation. “Back in 1979, almost all our research took place within the company,” John Lechleiter, Eli Lilly CEO

Comments Off on Eli Lilly: Partnerships Better than AcquisitionsRead this story »

AstraZeneca: Cancer Drug Challenges

AstraZeneca: Cancer Drug Challenges

By • on October 23, 2015

The Tech Times website reports that the biopharmaceutical company AstraZeneca has announced its decision to release the preclinical data from more than 50 of its medicines as part of the open innovation non-profit biology project called DREAM Challenges, which aims to find drug combinations that can

Comments Off on AstraZeneca: Cancer Drug ChallengesRead this story »

The Power of Open Innovation in Pharma

The Power of Open Innovation in Pharma

By • on October 14, 2015

The European CEO website noted that the pharmaceutical industry has suffered a significant decline in productivity in the last 25 years. Many industry observers cited a lack of internal innovation as a contributory factor to this reduction in productivity, and encouraged large pharmaceutical companies

Comments Off on The Power of Open Innovation in PharmaRead this story »

Singapore  Advancing Medical Research

Singapore Advancing Medical Research

By • on September 17, 2015

The Straits Times website noted that whereas pharmaceutical companies previously undertook their research in complete isolation from academia and from other companies, guarding their research closely in private laboratories, the past 10 or 15 years have seen companies and universities moving towards

Comments Off on Singapore Advancing Medical ResearchRead this story »

Pathways to Efficient Drug Development

Pathways to Efficient Drug Development

By • on August 21, 2015

The Netgadget website reported that collaboration and open innovation will play increasingly important roles in the future by enabling research that would not be possible for companies to undertake individually. Many examples exist, driven in large part by the FDAs Critical Path Initiative and the European

Comments Off on Pathways to Efficient Drug DevelopmentRead this story »

GSK, Crick Institute Partner on Open R&D

GSK, Crick Institute Partner on Open R&D

By • on August 8, 2015

The Drug Discovery and Development website reported that the Francis Crick Institute and GSK, the UK’s largest pharmaceutical company, are to partner on an open innovation collaboration exploring new avenues of medical research and drug discovery across a broad range of diseases. In the spirit of open

Comments Off on GSK, Crick Institute Partner on Open R&DRead this story »

Purchase viagra online and purchase it from the good to cope with dependable and trustworthy pharmacy. Don't believe of the recommendation by a mantra but instead as suggestion that is useful since that might be really a correct move to make to think about. It's not just about general ease of doing all of your buying resting before your Computer, or around no prerequisite to depart your home or stand-in point, but additionally concerning the choices you might have barely considered overall. Visit the drugstore you might have handled earlier in the event that you know the thing you need precisely. Examine the options what, why and just how if, nevertheless, you will find neither particular needs or a drugstore to go to.